ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Biogen Inc

Biogen Inc (1BIIB)

141.55
0.00
( 0.00% )
Actualizado: 08:26:33

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
141.55
Postura de Compra
140.25
Postura de Venta
141.30
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
141.45 Rango de 52 semanas 244.60
Capitalización de Mercado [m]
Precio Anterior
141.55
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
41
Acciones en circulación
145,719,340
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
18.38
Beneficio por acción (BPA)
7.97
turnover
9.84B
Beneficio neto
1.16B

Acerca de Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 141.55 €. Over the last year, Biogen shares have traded in a share price range of 141.45 € to 244.60 €.

Biogen currently has 145,719,340 shares in issue. The market capitalisation of Biogen is 20.63 € billion. Biogen has a price to earnings ratio (PE ratio) of 18.38.

1BIIB Últimas noticias

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1-0.701508242722142.55145.2141.4516141.59538462DE
4-12.05-7.84505208333153.6155.25141.4526149.31300813DE
12-29.35-17.1737858397170.9176.15141.4541162.23778169DE
26-77.45-35.3652968037219220.7141.4538172.98576497DE
52-92.65-39.560204953234.2244.6141.4534189.0019479DE
156-74.05-34.3460111317215.6244.6141.4533189.74711799DE
260-74.05-34.3460111317215.6244.6141.4533189.74711799DE

1BIIB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Biogen?
El precio actual de las acciones de Biogen es 141.55 €
¿Cuántas acciones de Biogen están en circulación?
Biogen tiene 145,719,340 acciones en circulación
¿Cuál es la capitalización de mercado de Biogen?
La capitalización de mercado de Biogen es EUR 20.63B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Biogen?
Biogen ha negociado en un rango de 141.45 € a 244.60 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Biogen?
El ratio precio/beneficio de Biogen es 18.38
¿Cuál es el ratio de efectivo a ventas de Biogen?
El ratio de efectivo a ventas de Biogen es 2.17
¿Cuál es la moneda de reporte de Biogen?
Biogen presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Biogen?
El último ingresos anual de Biogen es USD 9.84B
¿Cuál es el último beneficio anual de Biogen?
El último beneficio anual de Biogen es USD 1.16B
¿Cuál es la dirección registrada de Biogen?
La dirección registrada de Biogen es 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
¿Cuál es la dirección del sitio web de Biogen?
La dirección del sitio web de Biogen es www.biogen.com
¿En qué sector industrial opera Biogen?
Biogen opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WFTC26Finanzatech Spa
0.035 €
(40.00%)
30.1k
WSBCBSicily by Car SpA
0.0194 €
(29.33%)
9.3k
COSMOFarmacosmo spa
0.662 €
(10.33%)
25.2k
SOMSOMEC SpA
11.60 €
(7.91%)
7.7k
1SPCEVirgin Galactic Holdings Inc
6.70 €
(7.03%)
200
WIVN26iVision Tech SpA
0.2011 €
(-16.76%)
500
BSTBanca Sistema SpA
1.186 €
(-16.01%)
1.28M
1DUEDuerr AG
20.66 €
(-14.70%)
50
U24Ucapital24 Spa
0.532 €
(-12.50%)
60.4k
FDAFidia
0.0358 €
(-12.25%)
2.28M
TITTelecom Italia SpA
0.2403 €
(-0.62%)
133.81M
ISPIntesa Sanpaolo Spa
3.806 €
(-0.73%)
18.31M
SPMSaipem Spa
2.483 €
(0.04%)
11.6M
TITRTelecom Italia
0.2797 €
(-0.64%)
11.52M
ENELEnel Spa
6.807 €
(0.01%)
6.93M
tedpeele tedpeele 3 minutos hace
BFRI news: Share on X
Share on Reddit
Share on Facebook
12/23/2024 - 08:30 AM
Biofrontera started commercial distribution of the RhodoLED XL in June 2024 and has seen rapid uptake in the US market since launch.
The RhodoLED XL is approved by the FDA in combination
BFRI
powerbattles powerbattles 3 minutos hace
$LYT 1.17 loaded
LYT
Debunkinator Debunkinator 3 minutos hace
Can't wait to see the Holiday #'s 💰️
With remote work becoming the norm, gift cards are a prominent choice for most companies. A study conducted by Coresight Research showed that 48% of companies prefer offering digital gift cards to employees.

Offering a gift card can
ASII
branster branster 3 minutos hace
Got my shares this morning as promised, keep accumulating.
https://investorshub.advfn.com/uimage/uploads/2024/12/23/ajprvshares.jpg
NWBO
IronChefQuezon IronChefQuezon 3 minutos hace
I visited and talked to Ross and the Brewmaster there. Been a couple times. Good beer.
APRU
learningcurve2020 learningcurve2020 3 minutos hace
They've done everything in their power to keep everyone away including proper staffing, so why would you ever think that'd change? 
NWBO
TrendTrade2016 TrendTrade2016 3 minutos hace
ALTS LONG INTO 2025
ALTS
AMB67 AMB67 3 minutos hace
Someone check on them...

AtlasQ
Lovethatgreen
Splintered sunlight
Tiger Money
Kayak Wench
TillTom
LegendaryNomad23
Plinter1
Rum_Tequila
Rogers711
1Hunglo
Nunaka
Imanjen13
Rickstereo3333
RDGL
Renee Renee 3 minutos hace
OGSM: effective Dec. 24,2024 FINRA will delete the symbol as inactive security.

https://otce.finra.org/otce/dailyList?viewType=Deletions
OGSM
powerbattles powerbattles 3 minutos hace
Loaded 1.17
LYT
al44 al44 4 minutos hace
Science, suppression, and DEI

By Eric Utter


Common sense is not rocket science. But we may not have either soon.

All that said, I will take indigenous knowledge — and integrity — over ‘progressive’ science and the likes of Dr. Fauci. Any day.
Pittkid Pittkid 4 minutos hace
Message got canceled about dealing with it!  Remind me of.... lol
HMBL
oldstocks oldstocks 4 minutos hace
At least Mingothings is respectful
They at least post, but not OneMindNG or Affluence Corp

Google
94
MTi - Mingothings
+ Follow
MTi. international
1,363 followers
3d •0
• Happy Holidays from all of us at Mingothings
Inter
AFFU
CK-verse CK-verse 4 minutos hace
$HHSE-NEWS:..Best-Selling Author Barr-McClellan Reveals-Campaign-Insights and Strategies for Trump Victory in 2024 Election

https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for-trump-victory-in-2024-election
HHSE
silvr_surfr silvr_surfr 4 minutos hace
Great sleuthing JTFM as always. Like you have said before, don't watch for what they say, but what they do. This is great evidence that the Tezruly delay was planned. Sammy must be getting a good deal otherwise. Painful watching the stock near 52 week lows with all of the progress in the past ye
ANIP
McMagyar McMagyar 4 minutos hace
Closer and closer..
To me it's anticlimactic.. 
so many have died or gone beyond the point of no return for no reason other than Pfizer and Blackrock didn't want it to happen..
Too many memory care facilities to fill too many brain bleeds to prophet from.. what a sick business h
AVXL
DiscoverGold DiscoverGold 4 minutos hace
Today Boeing Company (BA) is the best performer in the DJIA
By: Thom Hartle | December 23, 2024

• Today (8:32 CST), the best performer in the DJIA is Boeing Company. BA.

pbs.twimg.com/media/GffYo6bWUAA_QO4?format=jpg&name=900x900

https://x.c
BA
flipper44 flipper44 4 minutos hace
Why don’t you bet against yourself? Reduce your posts by 99 to 1 if they get that upfront funding in the first quarter you keep saying they wont? 99% of you can take the bet against the 1% of you.
NWBO
Green Leaf Smoker Green Leaf Smoker 4 minutos hace
Ditto Ditto Ditto
PHIL
Renee Renee 4 minutos hace
PIPI: effective Dec. 24,2024 FINRA will delete the symbol as inactive security.

https://otce.finra.org/otce/dailyList?viewType=Deletions
PIPI
Invest-in-America Invest-in-America 5 minutos hace
RUM: Let's get ready to RUM -BULLLLLLLLLLLLL!!!!!!

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExdTdhcjg5Z3RoZGtobjB1eGtqbzVuNnMwYjZrZHdmdmtxNDJyYWprNSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/3aGZA6WLI9Jde/giphy.gif
RUM
georgie18 georgie18 5 minutos hace
VNCE...$6.30...🥳All out on the rest in the $6.30 Range from my $1.62 Alert...

georgie18

Member Level
Re: georgie18 post# 97

Friday, December 20, 2024 4:03:04 PM

Post#
98
of 99
VNCE...$4.57...🥳
VNCE
RMS555 RMS555 5 minutos hace
You missed your weekly fake update for the SCAM of PSRU!


PSRU IS A SCAM , YOU KNOW THIS...... Xavier Mitchell is a WANNABE!!!!


.
PSRU
ChannelTrader ChannelTrader 5 minutos hace
Thanks, and have a great Merry Christmas.
koolmc koolmc 5 minutos hace
been a sweet ride took most of the profits here, will just trade short term from now gl.
GBTC

Su Consulta Reciente

Delayed Upgrade Clock